Authors’ Reply to Alatorre et al.: “Cost Effectiveness of Guanfacine Extended-Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder: Application of a Matching-Adjusted Indirect Comparison”

Detalles Bibliográficos
Autores principales: Erder, M. Haim, Xie, Jipan, Signorovitch, James E., Chen, Kristina S., Hodgkins, Paul, Lu, Mei, Wu, Eric Q., Sikirica, Vanja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663979/
https://www.ncbi.nlm.nih.gov/pubmed/23592392
http://dx.doi.org/10.1007/s40258-013-0025-1
_version_ 1782271057595465728
author Erder, M. Haim
Xie, Jipan
Signorovitch, James E.
Chen, Kristina S.
Hodgkins, Paul
Lu, Mei
Wu, Eric Q.
Sikirica, Vanja
author_facet Erder, M. Haim
Xie, Jipan
Signorovitch, James E.
Chen, Kristina S.
Hodgkins, Paul
Lu, Mei
Wu, Eric Q.
Sikirica, Vanja
author_sort Erder, M. Haim
collection PubMed
description
format Online
Article
Text
id pubmed-3663979
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-36639792013-05-28 Authors’ Reply to Alatorre et al.: “Cost Effectiveness of Guanfacine Extended-Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder: Application of a Matching-Adjusted Indirect Comparison” Erder, M. Haim Xie, Jipan Signorovitch, James E. Chen, Kristina S. Hodgkins, Paul Lu, Mei Wu, Eric Q. Sikirica, Vanja Appl Health Econ Health Policy Correspondence Springer International Publishing 2013-04-17 2013 /pmc/articles/PMC3663979/ /pubmed/23592392 http://dx.doi.org/10.1007/s40258-013-0025-1 Text en © The Author(s) 2013 https://creativecommons.org/licenses/by-nc/2.5/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. The exclusive right to any commercial use of the article is with Springer.
spellingShingle Correspondence
Erder, M. Haim
Xie, Jipan
Signorovitch, James E.
Chen, Kristina S.
Hodgkins, Paul
Lu, Mei
Wu, Eric Q.
Sikirica, Vanja
Authors’ Reply to Alatorre et al.: “Cost Effectiveness of Guanfacine Extended-Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder: Application of a Matching-Adjusted Indirect Comparison”
title Authors’ Reply to Alatorre et al.: “Cost Effectiveness of Guanfacine Extended-Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder: Application of a Matching-Adjusted Indirect Comparison”
title_full Authors’ Reply to Alatorre et al.: “Cost Effectiveness of Guanfacine Extended-Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder: Application of a Matching-Adjusted Indirect Comparison”
title_fullStr Authors’ Reply to Alatorre et al.: “Cost Effectiveness of Guanfacine Extended-Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder: Application of a Matching-Adjusted Indirect Comparison”
title_full_unstemmed Authors’ Reply to Alatorre et al.: “Cost Effectiveness of Guanfacine Extended-Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder: Application of a Matching-Adjusted Indirect Comparison”
title_short Authors’ Reply to Alatorre et al.: “Cost Effectiveness of Guanfacine Extended-Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder: Application of a Matching-Adjusted Indirect Comparison”
title_sort authors’ reply to alatorre et al.: “cost effectiveness of guanfacine extended-release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder: application of a matching-adjusted indirect comparison”
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663979/
https://www.ncbi.nlm.nih.gov/pubmed/23592392
http://dx.doi.org/10.1007/s40258-013-0025-1
work_keys_str_mv AT erdermhaim authorsreplytoalatorreetalcosteffectivenessofguanfacineextendedreleaseversusatomoxetineforthetreatmentofattentiondeficithyperactivitydisorderapplicationofamatchingadjustedindirectcomparison
AT xiejipan authorsreplytoalatorreetalcosteffectivenessofguanfacineextendedreleaseversusatomoxetineforthetreatmentofattentiondeficithyperactivitydisorderapplicationofamatchingadjustedindirectcomparison
AT signorovitchjamese authorsreplytoalatorreetalcosteffectivenessofguanfacineextendedreleaseversusatomoxetineforthetreatmentofattentiondeficithyperactivitydisorderapplicationofamatchingadjustedindirectcomparison
AT chenkristinas authorsreplytoalatorreetalcosteffectivenessofguanfacineextendedreleaseversusatomoxetineforthetreatmentofattentiondeficithyperactivitydisorderapplicationofamatchingadjustedindirectcomparison
AT hodgkinspaul authorsreplytoalatorreetalcosteffectivenessofguanfacineextendedreleaseversusatomoxetineforthetreatmentofattentiondeficithyperactivitydisorderapplicationofamatchingadjustedindirectcomparison
AT lumei authorsreplytoalatorreetalcosteffectivenessofguanfacineextendedreleaseversusatomoxetineforthetreatmentofattentiondeficithyperactivitydisorderapplicationofamatchingadjustedindirectcomparison
AT wuericq authorsreplytoalatorreetalcosteffectivenessofguanfacineextendedreleaseversusatomoxetineforthetreatmentofattentiondeficithyperactivitydisorderapplicationofamatchingadjustedindirectcomparison
AT sikiricavanja authorsreplytoalatorreetalcosteffectivenessofguanfacineextendedreleaseversusatomoxetineforthetreatmentofattentiondeficithyperactivitydisorderapplicationofamatchingadjustedindirectcomparison

Ejemplares similares